ALK and lung adenocarcinoma: These results indicated that our constructed model helps to accurately and quickly quantify the ALK mutation status, which is critical in identifying of lung adenocarcinoma patients suitable for ALK-TKI therapy, and also provides potential possibilities for guiding immunotherapy.